[1] |
Welker MW,Trojan J. Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety[J]. Cancer Manag Res, 2013(5): 337-347.
|
[2] |
Barone M,Ettorre GC,Ladisa R, et al. Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma[J]. Hepatogastroenterology, 2003, 50(49): 183-187.
|
[3] |
王宇翾.原发性肝癌TACE术后并发症的分析[J].医学理论与实践, 2013, 26(12): 1609-1610.
|
[4] |
独建库,李冠海,张明德, 等.肝癌TACE术并发肝脓肿的临床特征及危险因素分析[J].临床军医杂志, 2012, 40(6): 1506-1508.
|
[5] |
Kim JW,Shin SS,Kim JK, et al. Radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of single hepatocellular carcinoma of 2 to 5 cm in diameter: comparison with surgical resection[J]. Korean J Radiol, 2013, 14(4): 626-635.
|
[6] |
Zhong JH,Xiang BD,Gong WF, et al. Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization[J]. PLoS One, 2013, 8(7): e68193.
|
[7] |
Cheung TT,Fan ST,Chan SC, et al. High-intensity focused ultrasound ablation: an effective bridging therapy for hepatocellular carcinoma patients[J]. World J Gastroenterol, 2013, 19(20): 3083-3089.
|
[8] |
Wang ZJ,Wang MQ,Duan F, et al. Clinical application of transcatheter arterial chemoembolization combined with synchronous C-arm cone-beam CT guided radiofrequency ablation in treatment of large hepatocellular carcinoma[J]. Asian Pac J Cancer Prev, 2013, 14(3): 1649-1654.
|
[9] |
Bojanović A,Bosnjaković P,Stojanović M, et al. Precision TACE in therapy of primary malignant tumors of liver/hepatocellular carcinoma (HCC)[J]. Acta Chir Iugosl, 2009, 56(4): 143-148.
|
[10] |
Sergio A,Cristofori C,Cardin R, et al. Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness[J]. Am J Gastroenterol, 2008, 103(4): 914-921.
|
[11] |
Cohen MJ,Bloom AI,Barak O, et al. Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma[J]. World J Gastroenterol, 2013, 19(16): 2521-2528.
|
[12] |
Naorungroj T,Naksanguan T,Chinthammitr Y. Pulmonary lipiodol embolism after transcatheter arterial chemoembolization for hepatocellular carcinoma: a case report and literature review[J]. J Med Assoc Thai, 2013, 96(Suppl 2): S270-S275.
|
[13] |
Jang ES,Yoon JH,Chung JW, et al. Survival of infiltrative hepatocellular carcinoma patients with preserved hepatic function after treatment with transarterial chemoembolization[J]. J Cancer Res Clin Oncol, 2013, 139(4): 635-643.
|
[14] |
Dhand S,Gupta R. Hepatic transcatheter arterial chemoembolization complicated by postembolization syndrome[J]. Semin Intervent Radiol, 2011, 28(2): 207-211.
|
[15] |
Favelier S,Boulin M,Hamza S, et al. Lipiodol trans-arterial chemoembolization of hepatocellular carcinoma with idarubicin: first experience[J]. Cardiovasc Intervent Radiol, 2013, 36(4): 1039-1046.
|
[16] |
李少华,陈敏山.经皮穿刺肝动脉化疗栓塞在肝细胞肝癌根治性切除术后的应用[J/CD].中华肝脏外科手术学电子杂志,2013,2(5):281-284.
|
[17] |
Honda Y,Kimura T,Aikata H, et al. Stereotactic body radiation therapy combined with transcatheter arterial chemoembolization for small hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2013, 28(3): 530-536.
|
[18] |
Nishikawa H,Arimoto A,Wakasa T, et al. Effect of transcatheter arterial chemoembolization prior to surgical resection for hepatocellular carcinoma[J]. Int J Oncol, 2013, 42(1): 151-160.
|